Passage BIO, Inc. (PASG) income statement
PASGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.92+0.31 (+8.59%)
Close on Nov 20, 2026Market cap $12.61MP/E –Yield –
Passage BIO, Inc. financial ratios
See a number that looks wrong?